AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEUREN PHARMACEUTICALS LTD

22.530

+0.0800.36%

Volume:727.76K

Turnover:16.49M

Market Cap:2.85B

PE:96.82

High:23.220

Open:23.200

Low:22.180

Close:22.450

52wk High:23.760

52wk Low:11.000

Shares:126.64M

Float Shares:108.39M

Volume Ratio:1.32

T/O Rate:0.67%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.233

EPS(LYR):0.233

ROE:8.67%

ROA:3.66%

PB:8.43

PE(LYR):96.82

Loading ...

Overview Company News Filings

Company Profile

Company Name:

NEUREN PHARMACEUTICALS LTD

Exchange:

ASX

Establishment Date:

2001

Employees:

8

Office Location:

117 Camberwell Road,Suite 1.01,Hawthorn East,Victoria,Australia

Website:

http://www.neurenpharma.com

Zip Code:

3123

Phone:

Fax:

- -

Introduction:

Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase III clinical trial for the treatment of Rett syndrome, as well as is in Phase II clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591 that is in preclinical development for the treatment of Phelan-McDermid, Angelman, and Pitt Hopkins syndromes. In addition, it provides development services; and holds loan funded shares. Neuren Pharmaceuticals Limited was incorporated in 1993 and is based in Camberwell, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/NEU.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NEU.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","market":"AU","secType":"STK","nameCN":"NEUREN PHARMACEUTICALS LTD","latestPrice":22.53,"timestamp":1787638320000,"preClose":22.45,"halted":0,"volume":727764,"delay":0,"changeRate":0.003563474387527922,"nameEN":"NEUREN PHARMACEUTICALS LTD","floatShares":108394581,"shares":126639526,"eps":0.2327,"marketStatus":"Not Yet Opened","change":0.08,"latestTime":"08-25 16:12:00 AEST","open":23.2,"high":23.22,"low":22.18,"amount":16493253,"amplitude":0.046325,"askPrice":22.58,"askSize":3404,"bidPrice":22.42,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.2327,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":22.45,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":1.318636,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"NEU.AU","preClose":22.45,"auctionPrice":22.53,"auctionVolume":150050,"auction":3,"marketStatus":"盘后竞价","timestamp":1787638203501}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"NEU.AU\",,,,,undefined,":{"symbol":"NEU.AU","floatShares":108394581,"roa":"3.66%","roe":"8.67%","lyrEps":0.2327,"volumeRatio":1.318636,"shares":126639526,"dividePrice":0,"high":23.22,"amplitude":0.046325,"preClose":22.45,"low":22.18,"week52Low":11,"pbRate":"8.43","psRate":"44.13","week52High":23.76,"institutionHeld":0,"latestPrice":22.53,"committee":-0.545867,"eps":0.2327,"divideRate":0,"volume":727764,"delay":0,"ttmEps":0.2327,"open":23.2,"prevYearClose":18.61,"prevWeekClose":22.46,"prevMonthClose":18,"prevQuarterClose":17.75,"fiveDayClose":23.04,"twentyDayClose":17.05,"sixtyDayClose":14.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEU.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787702400000,"name":null,"time":"","dateTimestamp":1787666400000,"actualEps":null},{"date":"2025-02-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740697200000,"name":null,"time":"","dateTimestamp":1740661200000,"actualEps":null},{"market":"AU","date":"2024-02-29","symbol":"NEU.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1709125200000,"reportTimeType":"","actualEps":null},{"date":"2023-08-28","symbol":"NEU.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693180800000,"name":null,"time":"","dateTimestamp":1693144800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEU.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":20376907,"yearFounded":2001,"employeeNum":8,"address":"117 Camberwell Road,Suite 1.01,Hawthorn East,Victoria,Australia","zipCode":"3123","officePhone":"61 3 9092 0480","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.neurenpharma.com","stockEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.3688},{"period":"3month","weight":0.6279},{"period":"6month","weight":0.6763},{"period":"1year","weight":0.2758},{"period":"ytd","weight":0.2106}],"compareEarnings":[{"period":"1week","weight":0.0117},{"period":"1month","weight":0.0326},{"period":"3month","weight":0.0637},{"period":"6month","weight":0.0332},{"period":"1year","weight":0.0993},{"period":"ytd","weight":0.0637}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. Its lead product is trofinetide, which is in Phase III clinical trial for the treatment of Rett syndrome, as well as is in Phase II clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591 that is in preclinical development for the treatment of Phelan-McDermid, Angelman, and Pitt Hopkins syndromes. In addition, it provides development services; and holds loan funded shares. Neuren Pharmaceuticals Limited was incorporated in 1993 and is based in Camberwell, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.062025},{"month":2,"riseRate":0.318182,"avgChangeRate":-0.048685},{"month":3,"riseRate":0.5,"avgChangeRate":0.342355},{"month":4,"riseRate":0.454545,"avgChangeRate":0.027357},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.029177},{"month":6,"riseRate":0.681818,"avgChangeRate":0.102868},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.0335},{"month":8,"riseRate":0.428571,"avgChangeRate":0.013034},{"month":9,"riseRate":0.619048,"avgChangeRate":0.114557},{"month":10,"riseRate":0.619048,"avgChangeRate":0.072663},{"month":11,"riseRate":0.47619,"avgChangeRate":0.032447},{"month":12,"riseRate":0.333333,"avgChangeRate":0.026009}],"exchange":"ASX","name":"NEUREN PHARMACEUTICALS LTD","nameEN":"NEUREN PHARMACEUTICALS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NEU.AU\",market:\"AU\",,,undefined,":null}}